Fondren Management’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-74
Closed -$217K 90
2019
Q1
$217K Buy
+74
New +$217K 0.17% 73